![Photo](/media/story/11605/thumbnail.jpg)
‘Huge progress’ in the ICU
You’ll find Élie Azoulay everywhere during this year’s International Symposium on Intensive Care and Emergency Medicine (ISICEM).
You’ll find Élie Azoulay everywhere during this year’s International Symposium on Intensive Care and Emergency Medicine (ISICEM).
How do our brains combine information from the external world (sensory stimulation) with information on our internal state such as hunger, fear or stress?
‘The disease “cancer” is increasingly classified into sub-groups. Today, we are already dealing with a number of orphan diseases,’ says Professor Richard Greil MD, head of LIMCR at University Hospital Salzburg.
Olympus launches its OlyVIA Mobile iPad App, an image viewer dedicated to virtual slides.
Poor growth in the first three months of pregnancy is associated with a range of cardiovascular risk factors in childhood, finds a study published on bmj.com.
Offering attractive procurement strategies will boost adoption of high-end tools
Down’s syndrome (also referred to as trisomy 21) is a genetic disorder caused by the presence of all or part of an extra copy of chromosome 21 in a person’s DNA. Current screening for Down’s syndrome and other trisomy conditions includes a combined test done between the 11th and 13th weeks of pregnancy.
Over the past decade the use of point-of-care testing (POCT) in European and North American hospitals has steadily increased, stimulated by the objectives of accelerating diagnostic treatment, increasing efficiency and improving patient outcomes.
Ahead of regulatory approval that is expected before the end of the year, Trinity Biotech chose Medica to present the novel point-of-care (POC) analyzer Meritas with the Troponin I (TnI) that are expected to disrupt a €700 million market.
The properties of copper in helping prevent nosocomial infections were debated this October at the Infection Prevention 2013 conference, when Professor Tom Elliott, Consultant Microbiologist at University Hospitals Birmingham NHS Foundation Trust, addressed the question: ‘Can the use of copper help prevent infection?’
Over the past 10 years the use of point-of-care testing (POCT) in in European and North American hospitals has steadily increased, stimulated by the objectives of accelerating diagnostic treatment, increasing efficiency and improving patient outcomes, Cynthia E. Keen reports
Using electrically conductive, ink-like materials, a Swedish consortium has created a fully functional prototype for a self-monitoring blood glucose (SMBG) test that could be disruptive for in vitro diagnostics.
Diarrhoea caused by Clostridium difficile, which remains an issue in hospital settings, has been the focus of Cochrane Collaboration scientists, who now suggest that taking probiotics at the same time as antibiotics could help to maintain a healthy balance of bacteria in the gut, particularly as antibiotics can disturb the ecosystem of organisms normally present in the digestive system.
Beckman Coulter’s new Access AccuTnI+3 troponin I assay has received FDA clearance for its UniCel DxI series of immunoassay systems at the same time as having a new CE Mark approved on the UniCel DxI and Access 2 immunoassay instruments.
Internet-based training for clinicians could help lower antibiotic prescribing rates for acute respiratory tract infections by as much as 62%, according to British researchers.
Clinical chemistry influences almost all medical disciplines: most diagnoses are made or confirmed only after the laboratory has determined at least one or two parameters.
Infusion solutions on the basis of HES (hydroxyethyl starch) are blood volume substitutes. They replace missing blood volume in patients with high blood loss, they stabilize the blood circulation and restore oxygen and nutrient supply to organs.
In intensive care units (ICUs) little can be automated to relieve staff pressures – with the exception of point of care testing (POCT)
Nat Whitney, President of Whitney Research, sums up the ups and downs of the international IVD market and reports on a fitting finale for 17 years of dedicated service
The Allegra X-5 air-cooled benchtop centrifuge from Beckman Coulter Life Sciences is designed specifically for clinical sample preparation.
Snibe, the Shenzhen New Industries Biomedical Engineering Company Ltd., is a leading Chinese biomedical technology company dedicated to developing and manufacturing clinical laboratory equipment and in vitro reagents. Founded 18 years ago and a growing force in the Chinese market, the firm is based in Shenzhen, China’s fourth largest city, situated in Guangdong Province.
908 Devices has good reason to be based in Boston’s Innovation District. A start-up founded in 2012, the company plans to disrupt the field of chemical analysis with what Vice President Chris Petty calls ‘ridiculously small, and elegantly simple’ mass spectrometry technology.
Mass spectrometry has been applied in advanced clinical research and drug discovery and development. Continual innovations have created capabilities to address complex analytical challenges qualitatively and quantitatively with unparalleled speed, sensitivity and accuracy
A 2012 study analysing the care of cancer patients in the USA in 138 Veterans’ Administration hospitals (pub: Journal of the National Cancer Institute) questions the effectiveness of tumour board review. The study measured effectiveness by comparing the presence of tumour review boards with stage-specific quality of care and patient outcomes.
Quality management (QM) for medical laboratories shaped its footprint during recent years – it’s a hot topic in papers, conferences and trade fairs. A lot of information makes a lot of work, says Dr Markus Neumann